The IRE website will be unavailable while we complete routine maintenance on Friday, September 17 from 8-10 am CT.
IRE favicon

Shop

Resource ID: #17826
Subject: Medicine
Source: Technology Review
Affiliation: 
Date: April

Description

Several ventures have been launched over recent years to "sift through the DNA of specific populations, in hope of identifying the underlying genetic causes of those diseases most likely to kill us. The researchers, pharmaceutical companies executives and venture capitalists involved are all betting that recent advances in biotech and computing have made it possible to take a few hundred or thousand victims of a disease, analyze their DNA, compare it to the DNA of healthy individuals, and identify the salient differences -- those genetic variations that result in illness on the one hand and health on the other...If these efforts succeed, they could revolutionize the nature of drug discovery and medical treatment." However, this type of research, called population genomics, brings up a host of ethical issues. For instance, some past studies use a standard of "presumed consent" for subject's participation in the study, as opposed to the "informed consent" required for most research.

This file is not available for digital download. IRE members may place an order by emailing rescntr@ire.org

141 Neff Annex   |   Missouri School of Journalism Columbia, MO 65211   |   573-882-2042   |   info@ire.org   |   Privacy Policy
apartmentpenciluserscalendar-fullcrossmenu linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram